Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

IBM

Investors Are Bullish on International Business Machines - Here's What You Need to Know.

International Business Machines surged to $259.11 per share this morning, but it remains 12.01% above its mean target price of $231.33. There may still be room for more downwards movement — even after today's 13.3% drop. Analysts are giving the Large-Cap Computer Hardware stock on average rating of hold, with target prices ranging from $139.0 to $290.0 per share.

The stock has an average amount of shares sold short at 2.3%, and a short ratio of 5.94. The company's insiders own 0.12% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 63.1% of International Business Machines's shares being owned by this investor type.

Institutions Invested in International Business Machines

Date Reported Holder Percentage Shares Value
2024-09-30 Vanguard Group Inc 10% 90,299,364 $23,397,466,883
2024-09-30 Blackrock Inc. 8% 77,541,977 $20,091,900,524
2024-09-30 State Street Corporation 6% 55,671,883 $14,425,140,788
2024-09-30 Geode Capital Management, LLC 2% 20,482,147 $5,307,128,809
2024-09-30 Bank of America Corporation 2% 17,434,587 $4,517,475,582
2024-09-30 Morgan Stanley 2% 14,147,286 $3,665,703,068
2024-09-30 JP Morgan Chase & Company 1% 12,101,374 $3,135,586,839
2024-09-30 Northern Trust Corporation 1% 9,141,784 $2,368,727,518
2024-09-30 Legal & General Group PLC 1% 9,041,630 $2,342,776,616
2024-09-30 Bank Of New York Mellon Corporation 1% 8,280,201 $2,145,482,759

Besides an analyst belief that shares are overpriced, other market factors point to there being negative market sentiment on International Business Machines.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS